NIH-funded research R01 grant

Obstructive sleep apnea and blood sugar control in adults with type 1 diabetes

Official title: Obstructive sleep apnea and glycemic dysregulation in adults with type 1 diabetes

Funded at University of Chicago · NIH-11412692 · Data updated 2026-11-12

This study tests whether treating sleep apnea improves blood sugar control in adults with type 1 diabetes who use insulin pumps and continuous glucose monitoring.

More Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startSeptember 15, 2024
Project endAugust 31, 2029
Funding year2026
Award (this year)$675,024
NIH project number5R01HL174685-03
Project IDNIH-11412692 on NIH RePORTER

Who could benefit from this research

Could help

Adults (21+) with type 1 diabetes and diagnosed obstructive sleep apnea who use an insulin pump and continuous glucose monitoring.

Less likely to help

Participants without obstructive sleep apnea or those not on CGM/insulin pump therapy may not benefit from this intervention.

What this research studies

If you have type 1 diabetes and sleep apnea, this study will compare what happens to your blood sugar and hormone responses when sleep apnea is untreated versus treated with CPAP over two 14-day periods. It uses a within-subject, cross-over design so participants experience both conditions in random order, with a 4-week washout between periods. Researchers will monitor sleep, hormones, lipids, and glucose using in-lab assessments and your CGM data to understand how sleep health affects glycemic control. The goal is to see if treating sleep apnea can reduce cardiovascular risk by improving glucose regulation in adults with type 1 diabetes.

Why it matters

Potential benefit: If successful, treating sleep apnea could improve blood sugar control and lower cardiovascular risk for adults with type 1 diabetes.

How similar studies have gone: Previous research supports a link between sleep apnea treatment and metabolic outcomes, but this study uses a rigorous cross-over design in type 1 diabetes.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Tasali, Esra — University of Chicago
  • Study coordinator: Tasali, Esra

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.